Navigation Links
First assessment of individual RLS domains in new post-hoc analyses of Neupro® studies
Date:4/25/2012

w.neupro.com/">www.neupro.com.

Neupro® in the U.S. Important Safety Information

Neupro® contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life threatening or less severe asthmatic episodes in certain susceptible people.

Patients treated with Neupro® have reported falling asleep while engaged in activities of daily living and somnolence. In clinical trials for the highest recommended Neupro® dose, the incidence of the treatment difference between Neupro® and placebo for somnolence was 16% for early-stage Parkinson's disease, 4% for advanced-stage Parkinson's disease, and 6% for Restless Legs Syndrome. Some patients perceived no warnings signs, such as excessive drowsiness. Patients should be advised to exercise caution while driving, operating heavy machinery or working at heights during treatment with Neupro®.

There is an increased risk for hallucinations in patients with advanced-stage Parkinson's disease treated with Neupro®. In clinical trials for the highest recommended Neupro® dose, the incidence of the treatment difference between Neupro® and placebo for hallucinations was 4%, and this difference increased with increasing dose. Patients also may experience new or worsening mental status and behavioral changes, which may be severe, including psychotic-like behavior during Neupro® treatment or after starting or increasing the dose of Neupro®.

Neupro® may cause symptomatic postural/orthostatic hypotension and syncope, especially during dose escalation, elevated blood pressure, elevated heart rate, weight gain and fluid reten
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
3. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Henry Schein to Webcast First Quarter 2012 Conference Call Tuesday, May 8, at 10:00 a.m. EDT
6. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
7. Insmed to Host 2012 First Quarter Earnings Conference Call
8. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
9. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
11. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces ... is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) today announced ... of 2013 on Monday, February 3, 2014. A press release ... of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... operating highlights and financial results for the fourth quarter and ...
(Date:1/14/2014)... -- Acumed,s new SLIC Screw System - a jointed ... place and insert the screw accurately - offers surgeons ... repair or reconstruction as it holds the bones reduced ... http://photos.prnewswire.com/prnh/20140114/MN45636 ) The SLIC Screw is ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... (Nasdaq: ERES ), a global provider of ... device industries, today announced that Michael McKelvey will be ... Officer and a director of ERT.  The Company,s Board ...  Dr. McKelvey will continue in his current position until ...
... Sept. 10 Covance Inc. (NYSE: CVD ) ... Global Healthcare Conference on Tuesday, September 14, 2010 at 2:10 ... presentation at www.covance.com .  In order to register and ... Covance, with headquarters in Princeton, New Jersey, is ...
Cached Medicine Technology:ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer 2ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer 3
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
(Date:4/17/2014)... MD, was recently invited to submit a review ... Microbiology , one of the world,s foremost scientific ... specialist, and chair of the Department of Pediatrics ... analyzed the epidemiology and microbiology of co-infections during ... as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... , , ORLANDO, Fla., ... new report today at its annual convention in Toronto acknowledging ... comes to dealing with conflicts between religious beliefs and same-sex ... conflict with their sexuality and faith, says this report acknowledges ...
... ... , ... Atlanta, GA (Vocus) August 5, 2009 -- CareFirst BlueCross BlueShield (CareFirst) today announced that ... in National Account Service Company LLC (NASCO), joining the Blue Cross and Blue Shield ...
... , , BOSTON, Aug. 5 ... management solutions, today reported unaudited financial results for the second quarter ended June ... ) , , Q2 Financial Highlights ... second quarter of 2009 was $23.5 million, compared to $13.6 million for the ...
... , , HARRISBURG, Pa., Aug. ... of Massage Therapy began drafting preliminary regulations that will protect ... Commonwealth Pedro A. Cortes. , , "By ... and training, we can provide the best and most up-to-date ...
... , , ST. PAUL, Minn., Aug. ... Extreme Makeover: Home Edition (EMHE) premieres its seventh season ... be among a select group as a Designated Charity for an ... Duluth/Superior area. The EMHE episode, air date to be announced at ...
... simply a marker for obesity is unclear , , WEDNESDAY, ... activates sex hormones throughout the body may also predict those ... study finds. , The protein, called sex hormone-binding globulin (SHBG), ... Researchers suspect it also plays a role in the development ...
Cached Medicine News:Health News:APA Releases Report on Sexuality Debate 2Health News:APA Releases Report on Sexuality Debate 3Health News:CareFirst Joins Partnership of Blues Plans as Owner of NASCO 2Health News:CareFirst Joins Partnership of Blues Plans as Owner of NASCO 3Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 2Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 3Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 4Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 5Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 6Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 7Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 8Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 9Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 10Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 11Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 12Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 13Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 14Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 15Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 16Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 17Health News:State Regulation of Massage Therapy Will Improve Public Health, Safety 2Health News:State Regulation of Massage Therapy Will Improve Public Health, Safety 3Health News:Memorial Blood Centers Joins Extreme Makeover: Home Edition As Designated Charity 2Health News:Memorial Blood Centers Joins Extreme Makeover: Home Edition As Designated Charity 3Health News:Sex Hormone Protein May Predict Type 2 Diabetes 2Health News:Sex Hormone Protein May Predict Type 2 Diabetes 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: